Impact News +++ LyondellBasell Posts Narrower Loss In Q4 (AFX) +++ LYONDELLBASELL Aktie +4,07%

RESMED Aktie

>RESMED Aktienkurs

225.8 EUR +4.8% (Tradegate)

Ask: 224.8 EUR / 30 Stück

Bid: 222.7 EUR / 30 Stück

Tagesumsatz: 142 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

RESMED Aktie über LYNX handeln

Intraday

1 Jahr

>RESMED Performance

1 Woche: -3,3%

1 Monat: +3,7%

3 Monate: -2,6%

6 Monate: -10,5%

1 Jahr: -11,4%

laufendes Jahr: +2,7%

>RESMED Aktie

Name:

RESMED INC. DL-,004

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US7611521078 / 895878

Symbol/ Ticker:

RME (Frankfurt) / RMD (NYSE)

Kürzel:

FRA:RME, ETR:RME, RME:GR, NYSE:RMD

Index:

S&P500

Webseite:

https://investor.resmed.c..

Profil:

ResMed Inc. is an innovative leader in the develop..
>Volltext..

Marktkapitalisierung:

31162.28 Mio. EUR

Unternehmenswert:

30694.7 Mio. EUR

Umsatz:

4392.95 Mio. EUR

EBITDA:

1672.99 Mio. EUR

Nettogewinn:

1201.48 Mio. EUR

Gewinn je Aktie:

8.2 EUR

Schulden:

707.19 Mio. EUR

Liquide Mittel:

1156.31 Mio. EUR

Operativer Cashflow:

1573.7 Mio. EUR

Bargeldquote:

1.11

Umsatzwachstum:

3.76%

Gewinnwachstum:

22.6%

Dividende je Aktie:

1.94 EUR

Dividendenrendite:

0.88%

Dividendenschätzung:

0.94%

Div. Historie:

13.11.25 - 0.51762€
14.08.25 - 0.5148€

>weitere anzeigen...

Insiderhandel:

4 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 1.991.563 USD.

Suchwörter:

RESMED

Letzte Datenerhebung:

30.01.26

>RESMED Kennzahlen

Aktien/ Unternehmen:

Aktien: 145.97 Mio. St.

Frei handelbar: 99.36%

Leerverk. Aktien: 7.83%

Rückkaufquote: 0.87%

Mitarbeiter: 10600

Umsatz/Mitarb.: 0.41 Mio. EUR

Analysten:

Analystenrating: Buy

Kursziel: 17.64%

Bewertung:

KGV: 25.7

KGV lG: 23.56

KUV: 7.17

KBV: 5.99

PEG-Ratio: 0.89

EV/EBITDA: 18.35

Rentabilität:

Bruttomarge: 59.21%

Gewinnmarge: 27.35%

Operative Marge: 33.52%

Managementeffizenz:

Gesamtkaprendite: 18.52%

Eigenkaprendite: 25.41%

>RESMED Peer Group

Gesundheit

>RESMED Chart & Kurs - NYSE

>RESMED News

30.01.26 - 09:39	ResMed declares $0.60 dividend (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

30.01.26 - 03:00	Why 4DMedical, Appen, Nine Entertainment, and ResMed shares are storming higher today (Fool)
	These shares are ending the week on a positive note. But why? The post Why 4DMedical, Appen, Nine Entertainment, and ResMed shares are storming higher today appeared first on The Motley Fool Australia....

30.01.26 - 01:00	ResMed (RMD) Q2 Earnings and Revenues Beat Estimates (Zacks)
	ResMed (RMD) delivered earnings and revenue surprises of +4.59% and +2.30%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?...

30.01.26 - 01:00	ResMed (RMD) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
	The headline numbers for ResMed (RMD) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals....

30.01.26 - 00:48	Why is the ResMed share price jumping 7% today? (Fool)
	This sleep disorder treatment giant delivered another three months of strong growth. The post Why is the ResMed share price jumping 7% today? appeared first on The Motley Fool Australia....

30.01.26 - 00:36	ResMed (RMD) Q2 2026 Earnings Call Transcript (Fool)
	Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...

29.01.26 - 23:54	ResMed übertrifft Gewinnprognose für Q2 2026, Aktie gibt dennoch nach/n (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

29.01.26 - 23:36	Resmed posts Q2 FY26 earnings growth, lifts dividend (Fool)
	Resmed posts double-digit revenue and profit growth in Q2 FY26, declares dividend, and outlines plans for innovation. The post Resmed posts Q2 FY26 earnings growth, lifts dividend appeared first on The Motley Fool Australia....

29.01.26 - 22:36	Resmed Inc Q2 Profit Advances (AFX)
	WASHINGTON (dpa-AFX) - Resmed Inc (RMD.AX) released earnings for its second quarter that Increases, from last yearThe company's earnings totaled $392.59 million, or $2.68 per share. This compares ......

29.01.26 - 22:12	ResMed Non-GAAP EPS of $2.81 beats by $0.09, revenue of $1.4B in-line (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

29.01.26 - 22:09	Resmed Inc. Announces Results for the Second Quarter of Fiscal Year 2026 (GlobeNewswire EN)
	Note: A webcast of Resmed's conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com...

28.01.26 - 19:45	Will ResMed (RMD) Beat Estimates Again in Its Next Earnings Report? (Zacks)
	ResMed (RMD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report....

27.01.26 - 16:45	Stay Ahead of the Game With ResMed (RMD) Q2 Earnings: Wall Street′s Insights on Key Metrics (Zacks)
	Besides Wall Street's top-and-bottom-line estimates for ResMed (RMD), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025....

27.01.26 - 15:15	Resmed′s Q2 Earnings on Deck: What′s in Store for the Stock? (Zacks)
	RMD is set to report Q2 results on Jan. 29, with revenues likely to jump 8.3% and EPS 10.3% as masks, devices and software drive growth....

26.01.26 - 17:30	Why ResMed (RMD) is a Top Growth Stock for the Long-Term (Zacks)
	Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores....

22.01.26 - 17:30	ResMed (RMD) Earnings Expected to Grow: What to Know Ahead of Next Week′s Release (Zacks)
	ResMed (RMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....

15.01.26 - 16:00	Here′s How Much a $1000 Investment in ResMed Made 10 Years Ago Would Be Worth Today (Zacks)
	Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more....

13.01.26 - 17:30	Why ResMed (RMD) is a Top Momentum Stock for the Long-Term (Zacks)
	The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage....

09.01.26 - 17:01	Insiderhandel: Aufsichtsrat verkauft Aktien von ResMed im Wert von 497660 USD (Insiderkauf)
	Farrell, Peter C. - Aufsichtsrat - Tag der Transaktion: 2026-01-07...

09.01.26 - 01:02	Insiderhandel: Chairman and CEO verkauft Aktien von ResMed im Wert von 1240065 USD (Insiderkauf)
	Farrell, Michael J. - Vorstand - Tag der Transaktion: 2026-01-07...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Einen wohlbedächtigen Feldherrn zieh ich einem kecken vor. - Euripides

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram